| Target Price | zł498.27 |
| Price | zł405.00 |
| Potential |
23.03%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Creepy Jar 2026 .
The average Creepy Jar target price is zł498.27.
This is
23.03%
register free of charge
zł609.00
50.37%
register free of charge
zł434.30
7.23%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Creepy Jar to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Creepy Jar stock has an average upside potential 2026 of
23.03%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million zł | 30.98 | 29.29 |
| 17.39% | 5.46% | |
| EBITDA Margin | 48.71% | 47.42% |
| 8.34% | 2.65% | |
| Net Margin | 51.32% | 57.01% |
| 5.00% | 11.08% |
4 Analysts have issued a sales forecast Creepy Jar 2025 . The average Creepy Jar sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Creepy Jar EBITDA forecast 2025. The average Creepy Jar EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Creepy Jar Analysts have issued a net profit forecast 2025. The average Creepy Jar net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share zł | 21.86 | 23.86 |
| 16.37% | 9.15% | |
| P/E | 16.98 | |
| EV/Sales | 7.23 |
3 Analysts have issued a Creepy Jar forecast for earnings per share. The average Creepy Jar EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ERSTE GROUP |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| SANTANDER BROKERAGE POLAND |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | May 29 2025 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | May 28 2025 |
| ERSTE GROUP |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
| IPOPEMA SECURITIES |
Locked
➜
Locked
|
Locked | Dec 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
ERSTE GROUP:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
SANTANDER BROKERAGE POLAND:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
Sep 29 2025 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
May 29 2025 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
May 28 2025 |
|
Locked
ERSTE GROUP:
Locked
➜
Locked
|
Jan 23 2025 |
|
Locked
IPOPEMA SECURITIES:
Locked
➜
Locked
|
Dec 08 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


